Shanghai Zhongshan Hospital: Hypertension, Portal trials
The registry lists 12 Hypertension, Portal studies with Shanghai Zhongshan Hospital as lead sponsor. 5 are open to participants now and 0 have results posted.
No phase 12(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Optimizing Endoscopic and Interventional Treatment for Portal Hypertensive BleedingNot yet recruitingNCT07502729
- Indicators Affecting PVT RecanalizationRecruitingNCT07473375
- Construction of a Portal Hypertension BiobankRecruitingNCT07419724
- Treatment Outcomes for Portal Hypertension Esophageal and Gastric VaricesRecruitingNCT07358663
- Improve the Strategies of Endoscopic and Interventional Treatment of Gastroesophageal Hemorrhage in Portal HypertensionRecruitingNCT06970509
- Effectiveness of Treatments for Cirrhosis With Varicose VeinsActive, not recruitingNCT06961474
- Gastroesophageal Varices in CavernomaStatus unknownNCT04525768
- Oxaliplatin-induced Portal HypertensionStatus unknownNCT04524676Not applicable
- Early Diagnosis of Oxaliplatin-induced Portal HypertensionStatus unknownNCT04524650
- The Influence of Post-transjugular Intrahepatic Portosystemic Shunt Hepatic EncephalopathyStatus unknownNCT03825848Not applicable
- Noninvasive Diagnostic Platform for Liver Fibrosis and Portal HypertensionStatus unknownNCT03277651
- Injection of Cyanoacrylate+Lipiodol vs Cyanoacrylate+Lauromacrogol in Gastric VaricesCompletedNCT01923064Not applicable